Misquoted: Experts clarify on Lancet study claiming protection offered by Covishield declines after 3 months

Published On 2021-12-25 10:10 GMT | Update On 2021-12-25 10:10 GMT

New Delhi: The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca Covid-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.

Speaking to ANI about the Lancet study on Covishield waning antibodies after 90 days, experts say that study has been misquoted.

Dr JA Jayala, President, IMA, said, "Most of the scientific data that is available says that vaccines provide antibodies and T cell immunity as well. It is based on certain facts. Most of the scientific data is available and the studies which have been conducted wide across the country and abroad have proved that antibody is not just stopping but it is continuing."

"But we are concerned about the T cell immunity or/and cellular immunity which is long lasting by all chances and once you are getting infected with the virus or when you are getting the passive immunity by the Covishield, definitely you will have the effect of that sustaining for a longer time. It will be preventing you and helping you to come out of the severe infection you are getting," the Indian Medical Association President said.

"Unfortunately, this study has a strange methodology, which none of us, including my peers, had ever seen before... So my point is, without discrediting the study authors, methodologies are very important when we come to understanding conclusions. So my message is that one should never blindly jump to conclusions. This study is based on the author's conclusions," he said.

"Always look at the methodology and see the data. And if we don't understand, run it by somebody who knows it before jumping to a conclusion. Unfortunately, the study has been misquoted. And all over the world, there's panic among people who've taken AstraZeneca vaccine," said Dr Rajeev Jayadevan, Vice Chairman Research Cell Kerala State IMA.

"Even till December 23, no decline has been observed as far as the protection offered by both vaccines, Covishield and Covaxin is concerned. No signal has come from anywhere in India that people are suddenly falling sick after taking these vaccines," Dr Rajeev added.

As India reported 236 Omicron cases as till December 23, the government and medical experts have appealed to people to follow Covid-19 appropriate behaviour. "Specifically, I'll focus on just one thing. Don't hang around people inside a closed room where people are talking, cheering or singing or having festivities. If you want to meet people, meet them outside or in open premises," Dr Rajeev said.

He further added, "We learned in the last two years to use masks. Everybody wears masks. Masks are important. You know why? Because many people who carry the virus do not know they're infected. So if they're wearing a mask, they're reducing the number of viruses in the air. And so, they're protecting other people. So, that is the main purpose of wearing a mask."

Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Misquoted: Experts clarify on Lancet study claiming protection offered by Covishield declines after 3 months

Similar News

NPPA Approves Separate Price for GSK's New Paracetamol-Phenylephrine Sachet

Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report

Intas Pharma appoints Umesh Gupta as Associate Executive Vice President - Manufacturing Operations

Raid in Paschim Vihar: Counterfeit medicine racket busted

Syngene International appoints Gaurav Kushwaha as new Chief Technology Officer

GSK, Hengrui Pharma to develop up to 12 medicines across Respiratory, Immunology & Inflammation and Oncology

AstraZeneca Imfinzi gets USFDA priority review for resectable early stage gastric, gastroesophageal junction cancers

Bristol Myers Squibb, Bain Capital form new biopharmaceutical company - NewCo